VTB Bank issued the “Pharmasyntez” a loan of 2 billion rubles for the construction of a plant for the production of anticancer drugs in St. Petersburg. About it reports TASS.
As explained in the Bank, financing is carried out in the framework of the Ministry of industry and trade, aimed at supporting increasing the volume of production and sales competitiveness of Russian industrial products. The size of the subsidy interest rate is 4.5% per annum.
Currently, the “pharmasyntez-Nord” implements the investment project for the construction of the second phase of a pharmaceutical plant anticancer drugs. The investment project aimed at further reducing the share of import medicines in the Russian market. The production of the plant is planned to be realized not only in Russia but in the CIS countries and far abroad.
Earlier VTB has financed the construction of the first plant “Parasites-Nord” on the territory of the SEZ. The total investment in the project will amount to 3 billion rubles. Start of production is scheduled for the first half of 2021.